The accuracy of nasal nitric oxide testing in PCD diagnostics is population specific
The accuracy of nasal nitric oxide testing in PCD diagnostics is population specific
Background: Nasal nitric oxide (nNO) is usually low in primary ciliary dyskinesia (PCD) and measurement is part of a complex diagnostic work-up. Previous research has failed to define the accuracy of nNO testing in differing patient populations.
Aims: Use accuracy data of nNO testing in patients referred to a UK national diagnostic service to calculate the predictive value of nNO testing in children with persistent wet cough (estimated 5% PCD prevalence) and in the general population (1:10,000 prevalence).
Methods: From June 2006 to January 2014, 282 consecutive referrals (aged 6-79 years) had nNO measured by breath hold technique on the chemiluminescent NIOX Flex analyser. PCD was diagnosed by high resolution video microscopy and quantitative electron microscopy. Sensitivity and specificity was calculated and used to derive positive and negative predictive values (PPV & NPV) for each population.
Results: 31 patients were PCD positive. Using a published cut-off of 77 nl/min (256 parts per billion on NIOX Flex), sensitivity was 93.6% (95% CI 78.5-99.0) and specificity 84.1% (95% CI 78.9-88.4). PPV was 42% (30.2-54.5%) and NPV 99.1% (96.6-99.9%) for referrals (prevalence of PCD 11%). PPV was 23.6% for persistent wet cough and <0.1% for general population.
Conclusion: PPV is poor and diminishes rapidly with lower PCD prevalence therefore screening should be targeted at those with high clinical suspicion of PCD. Whilst NPV is excellent, it must be interpreted alongside clinical history given published cases of PCD with normal nNO. These findings highlight the importance of using clinical features to select those who undergo nNO testing.
Collins, Samuel
bb947a91-8f30-49c2-a23c-6898103c7aa1
Behan, Laura
cf1a7b5e-64c5-4b02-8db2-7ad96781d40d
Evans, Hazel
722c5b0a-e32d-431b-ab45-7050bee983d1
Goggin, Patricia
90c80d17-9f7a-4401-8e6f-919c63efe5e6
Harris, Amanda-Lea
26fbd4db-b04a-4731-adb7-f661b1ef1436
Jackson, Claire
64cdd6fa-74c3-4ac6-94ef-070620a6efd9
Packham, Samantha
8512c637-42ab-40c6-883a-b66991573270
Walker, Woolf
0758e514-9212-4388-8879-e5a2dca3dbaa
Lucas, Jane
5cb3546c-87b2-4e59-af48-402076e25313
1 September 2015
Collins, Samuel
bb947a91-8f30-49c2-a23c-6898103c7aa1
Behan, Laura
cf1a7b5e-64c5-4b02-8db2-7ad96781d40d
Evans, Hazel
722c5b0a-e32d-431b-ab45-7050bee983d1
Goggin, Patricia
90c80d17-9f7a-4401-8e6f-919c63efe5e6
Harris, Amanda-Lea
26fbd4db-b04a-4731-adb7-f661b1ef1436
Jackson, Claire
64cdd6fa-74c3-4ac6-94ef-070620a6efd9
Packham, Samantha
8512c637-42ab-40c6-883a-b66991573270
Walker, Woolf
0758e514-9212-4388-8879-e5a2dca3dbaa
Lucas, Jane
5cb3546c-87b2-4e59-af48-402076e25313
Collins, Samuel, Behan, Laura, Evans, Hazel, Goggin, Patricia, Harris, Amanda-Lea, Jackson, Claire, Packham, Samantha, Walker, Woolf and Lucas, Jane
(2015)
The accuracy of nasal nitric oxide testing in PCD diagnostics is population specific.
European Respiratory Journal, 46 (suppl 59).
(doi:10.1183/13993003.congress-2015.PA4517).
Abstract
Background: Nasal nitric oxide (nNO) is usually low in primary ciliary dyskinesia (PCD) and measurement is part of a complex diagnostic work-up. Previous research has failed to define the accuracy of nNO testing in differing patient populations.
Aims: Use accuracy data of nNO testing in patients referred to a UK national diagnostic service to calculate the predictive value of nNO testing in children with persistent wet cough (estimated 5% PCD prevalence) and in the general population (1:10,000 prevalence).
Methods: From June 2006 to January 2014, 282 consecutive referrals (aged 6-79 years) had nNO measured by breath hold technique on the chemiluminescent NIOX Flex analyser. PCD was diagnosed by high resolution video microscopy and quantitative electron microscopy. Sensitivity and specificity was calculated and used to derive positive and negative predictive values (PPV & NPV) for each population.
Results: 31 patients were PCD positive. Using a published cut-off of 77 nl/min (256 parts per billion on NIOX Flex), sensitivity was 93.6% (95% CI 78.5-99.0) and specificity 84.1% (95% CI 78.9-88.4). PPV was 42% (30.2-54.5%) and NPV 99.1% (96.6-99.9%) for referrals (prevalence of PCD 11%). PPV was 23.6% for persistent wet cough and <0.1% for general population.
Conclusion: PPV is poor and diminishes rapidly with lower PCD prevalence therefore screening should be targeted at those with high clinical suspicion of PCD. Whilst NPV is excellent, it must be interpreted alongside clinical history given published cases of PCD with normal nNO. These findings highlight the importance of using clinical features to select those who undergo nNO testing.
This record has no associated files available for download.
More information
Published date: 1 September 2015
Additional Information:
Copyright ©ERS 2015
Identifiers
Local EPrints ID: 469963
URI: http://eprints.soton.ac.uk/id/eprint/469963
ISSN: 0903-1936
PURE UUID: 40d3e012-2fed-414e-9732-f58f3430d4ba
Catalogue record
Date deposited: 29 Sep 2022 16:39
Last modified: 17 Mar 2024 03:02
Export record
Altmetrics
Contributors
Author:
Samuel Collins
Author:
Laura Behan
Author:
Hazel Evans
Author:
Patricia Goggin
Author:
Amanda-Lea Harris
Author:
Claire Jackson
Author:
Samantha Packham
Author:
Woolf Walker
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics